Sage Journals: Discover world-class research

Abstract

Introduction:

Bisphenol A is a synthetic compound widely used in the production of polycarbonate plastics and epoxy resins worldwide. As an environmental toxin, it has been reported in plastic equipment and utensils, water bottles and bottle tops, water supply pipes and epoxy resins that coat most of the metal food cans. It is a known endocrine-disrupting chemical and has been progressively replaced by its derivatives including bisphenol S, bisphenol F, bisphenol E, bisphenol AF, bisphenol B and tetramethyl bisphenol F. Bisphenol A and its analogues can bind to estrogen receptors and trigger multiple cellular responses at the organism level.

Methods:

A comprehensive literature review was done utilising electronic databases of PubMed, Google Scholar, Hinari, Connected papers and Science Direct from 1991 onwards. The articles were only included if they reported original relevant research and were limited to articles written in English.

Results:

Animal models, including non-human primates, have been used to study their effects on the endocrine system. Its endocrine disruption activity is reported to be the most studied effect in reproductive biology indicating that it may potentially cause endometriosis in females. Though non-human primates are closely related to humans, limited data exists on their associations between Bisphenol A exposure and its analogues and the pathophysiology of endometriosis.

Conclusion:

Given the current multifaceted knowledge/theory on endometriosis etiology, there is a strong necessity to conduct further biomedical research that utilises non-human primates to study the link between endocrine-disrupting chemicals and its effects on endometriosis.

Keywords

Bisphenol A bisphenol A analogues endometriosis endocrine non-human primates

Introduction

Endometriosis is a benign inflammatory and estrogen-dependent gynecological condition characterised by the presence of endometrial glands and stroma outside the uterine cavity.¹ Global epidemiological studies show that endometriosis affects 10% of reproductive-aged females with annual incidences ranging from 0.12% to 0.72%.¹ The disease’s incidence has risen, however, it is unclear whether this rise is due to disease awareness or environmental contamination.²

It has an idiopathic etiology accompanied by different theories of pathogenesis.³ Recent reports indicate that endometriosis is likely attributed to a sundry of endocrine-disrupting chemicals including; bisphenol A (BPA), phthalates, polychlorinated biphenyl (PCBs), atrazine, polybrominated biphenyls (PBBs),⁴ dichlorodiphenyltrichloroethane (DDT),⁵ dichlorodiphenyldichloroethylene (DDE), dichlorodiphenyldichloroethane (DDD), diethylstilbestrol (DES) and dioxins (TCDD).⁶ One of the proposed etiological mechanisms is Sampson’s theory of retrograde menstruation which seems to be the most coherent and explains cases of endometriosis in the pelvis minor.⁷ The theory supposes that backflow of endometrial tissues during menstruation into the abdomen results in implantation.⁸ Further theories including coelomic metaplasia, lymph vascular metastasis or the embryonic rest theory have been complemented by more recent concepts including lifestyle-related factors, stem cells, hormonal,^9,10 immune dysfunction, environmental pollution and/or exposure to bisphenols,¹¹ and genetic or epigenetic aspects.¹²

Despite the presence of multiple theories of endometriosis pathogenesis, the environmental factors that could also pose a threat to and pathogenesis of the disease warrant investigation. To tackle this, experimental investigations including animal models could provide a basis for exploring the proposed association between endocrine-disrupting environmental toxins, such as Bisphenol-A (BPA) exposure and endometriosis development.¹³ Numerous efforts have been made to utilise experimental animals, mostly mice¹⁴ and a few non-human primates (NHPs).¹⁵ models in the study of BPA exposure and endometriosis.

The exposure of BPA and other Endocrine Disrupting Chemicals (EDCs) to the reproductive system renders serious abnormalities that may lead to impaired fertility, irregular menstrual patterns, Polycystic Ovary Syndrome (PCOS) and endometriosis.¹⁶ EDCs disrupt normal hormone function by either mimicking or blocking hormones and causing adverse health effects.¹⁷ Long-term exposure to the EDCs can lead to disorders in reproductive-aged females that may be transgenerational. Several studies have reported on the association of BPA and female fecundity, with BPA being detected more frequently in infertile women.¹⁶ Furthermore, BPA experimental research shows that its effects are more critical during prenatal, perinatal and postnatal exposure in the pup’s early life stages and may have transgenerational.¹⁸

Therefore, this review focuses on the effects of BPA and its analogues (Bisphenol S (BPS), Bisphenol F (BPF), Bisphenol E (BPE), Bisphenol F (BPAF) and Bisphenol B (BPB)) on the pathophysiology of endometriosis disease in NHPs as a surrogate for human disease.¹⁹

Methodology

The literature search was done using the electronic databases of Google Scholar, Science Direct (Elsevier), PubMed, Hinari and Connected Papers websites restricted to the period between 1991-2022. The search terms used included; ‘non-human primates’, ‘endometriosis’, ‘bisphenol A,’ ‘bisphenols analogues’ and ‘animal models. The reference lists of all selected articles were reviewed to identify additional papers and the search was limited to articles written in English. Inclusion/Exclusion criteria are listed in Table 1.

Table 1.

Details of the inclusion and exclusion criteria.

Topics	Inclusions	Exclusions
Study design	Experimental studies that investigate effects of BPA and its analogues in NHPsIncludes designs such as in vivo experiments, longitudinal studies and controlled trials, including cross-sectional studies	Excludes any case reports, opinion pieces and review articles that do not present original research.²⁰
Animal models	Includes studies specifically conducted on NHPs (monkeys and baboons) as the primary subjects including non-primate models for the purpose of comparison	Eliminates studies involving animals that are not directly relevant to exposure to BPA as a potential cause of endometriosis
Exposure	Includes studies that use BPA and its analogues as the exposure elementAlso includes studies with information on the dose, durations and the method of exposure to BPA and its analogues	Omits studies that do not involve exposure to BPA and its analogues and also studies whose exposure details are unclear or not-well documented.¹²
Outcome	Contains studies that report on endometriosis as the outcome or studies that investigate markers, symptoms or histological evidence associated with endometriosis	Excludes studies that do not report on endometriosis as an outcome and any that focuses on other reproductive or gynecological related health outcomes without any connection to endometriosis
Publication type	Covers peer-reviewed journal articles and reviews (narrative, systematic and meta-analyses)	Disregards studies that are not published in English for ease of review.²¹
Publication timeframe	Goes back 30 years	Studies older than 30 years

BPA and its analogues as potential cause of endometriosis

As defined by the World Health Organisation (WHO), EDCs are exogenous substances that alter the function(s) of the endocrine system and cause adverse effects on the organism, its progeny and subpopulations.²² EDCs are thought to contribute to the pathogenesis of endometriosis, via their ability to mimic the hormone functions of the endocrine system. BPA and its analogues are EDCs that are universally present among common consumer products.²³ Reports indicate that a large amount of natural and man-made chemical toxins are present within our surroundings, hence both animals and humans are exposed to them.²² Table 2 provides a summary of epidemiological and experimental studies of exposure to BPA and its analogues, whereas Table 3 summarises studies on exposure to BPA and its analogues using human samples.

Table 2.

Epidemiological summary of studies of exposure to bisphenol A and its analogues.

Authors	Bisphenols	Experimental models	Samples	No. of samples	Country of collected samples
Human samples
Peinado et al.²⁴	Bisphenol A	Human samples	Urine	124	Spain
Cobellis et al.²⁵		Human samples	Human blood sera	58	Italy
Rashidi et al.²⁶		Human samples	Urine	50	Iran
Wen et al.²⁷		Human samples	Endometrial stromal cells	320	China
Peinado et al.²⁴	Bisphenol S	Human samples	Urine	124	Spain
Peinado et al.²⁴	Bisphenol F	Human samples	Urine	124	Spain
Cobellis et al.²⁵	Bisphenol B	Human samples	Human blood sera	58	Italy
NHPs
Aldad et al.²⁸	Bisphenol A	African green monkey	Ovaries	10	USA
Calhoun et al.¹⁵		Rhesus macaques	Foetal uteri	4	USA
Non-primates
Pivonello et al.¹⁸		Rats	Endometrial tissues	Review	Italy
Jones et al.¹⁷		Mouse	Lesions, ovaries and blood	25	USA
Xue et al.¹⁴		Mouse and clinical samples	Endometrial stromal cell lines	22	China
Signorile et al.²⁹		Mouse	Pelvic organs	60	Italy
Signorile and Baldi³⁰		Mouse	Pelvic organs	Review	Italy
Shi et al.³¹		Mice	Neonatal ovary	25	Illinois, USA
Abdel-Wahab et al.³²		Rat	Blood and tissue	40	Egypt
Kendziorski and Belcher³³		Mice	Endometrial tissues	2	USA
Horan et al.³⁴	Bisphenol S	Mouse	ovary	Review	USA
Shi et al.³¹		Mice	Neonatal ovary	25	Illinois, USA
Hill et al.²³		Mice	Ovary and uterus	15	USA
Shi et al.³¹	Bisphenol E	Mice	Neonatal ovary	25	Illinois, USA
Jones et al.¹⁷	Bisphenol AF	Mice	Lesions, ovary and blood	25	USA

Table 3.

Summary of studies on exposure to BPA and its analogues using human samples.

Authors	Bisphenols	Sample type	Objective	Risk effects (odds ratio and relative risks)
Peinado et al.²⁴	Bisphenol A	Human samples	To explore associations of urinary concentrations of bisphenols A (BPA), S (BPS) and F (BPF) and of thiobarbituric acid reactive substances (TBARS) with the risk of endometriosis in women of childbearing age.	Increases the risk of endometriosis development with an odds ratio of 3.7
Cobellis et al.²⁵		Human samples	Determination of bisphenol A (BPA) and bisphenol B (BPB) in human blood serum	Enhances the sensitivity of endometriosis cells with a relative risk of 63.8% leading to endometriosis
Rashidi et al.²⁶		Human samples	To evaluate the relationship between urinary BPA concentrations in women with endometrioma	Positive association between urinary BPA and endometrioma developments
Wen et al.²⁷		Human samples	to evaluate the relationships between BPA exposure and matrix metalloproteinase (MMP) 2 and 9 expressions and the risk of EM subtypes	promotes peritoneal endometriosis with an odds ratio of 3.7
Peinado et al.²⁴	Bisphenol S	Human samples	To explore associations of urinary concentrations of bisphenols A (BPA), S (BPS) and F (BPF) and of thiobarbituric acid reactive substances (TBARS) with the risk of endometriosis in women of childbearing age.	increases the risks of endometriosis development with an odds ratio of 3.7
Peinado et al.²⁴	Bisphenol F	Human samples	To explore associations of urinary concentrations of bisphenols A (BPA), S (BPS) and F (BPF) and of thiobarbituric acid reactive substances (TBARS) with the risk of endometriosis in women of childbearing age.	increases the risks of endometriosis development with an odds ratio of 3.7
Cobellis et al.²⁵	Bisphenol B	Human samples	Determination of bisphenol A (BPA) and bisphenol B (BPB) in human blood serum	Enhances the sensitivity of endometriosis cells with a relative risk of 63.8% leading to endometriosis

The female reproductive system is very sensitive to hormonal imbalances and modifications of the endocrine system’s functions.³⁵ Generally, BPA is a well-studied EDC and can interfere with human hormonal balance even at long-lasting low-dose exposure.³⁶ Upon exposure, as a selective Estrogen Receptor (ER) modulator, BPA has been shown to bind to estrogen, thyroid, glucocorticoid, peroxisome proliferator-activated receptors and steroid enzymes among other molecular targets.³⁷ It then interferes with the gene expression of several estrogen (ER) receptor subtypes (ERα, ERγ and ERβ) and can subsequently cause pleiotropic effects on the reproductive system, behaviour and metabolism.³⁸ BPA interrupts the foetal pulsatile secretion of Gonadotrophin-Releasing Hormone (GnRH) which negatively affects the function of the hypothalamic-ovarian axis.³⁶ As a result, continuous pre-and postnatal exposure induces future structural changes to the female reproductive system (ovary and uterus), leading to abnormalities and possibly diseases like endometriosis. Additionally, several BPA alternatives (BPS, BPB, BPF and BPE) have also been implicated in having similar effects to BPA on the endocrine system, thereby negating their safety. Among the analogues,³⁹ tetramethyl bisphenol F (TMBPF) is reported to be the most recently produced.⁴⁰

Use of animal models for BPA exposure

NHP models for BPA exposure

Studies on the effects of BPA exposure using NHPs have been done using both baboons (Old World Monkeys) and macaques (New World Monkeys). However, the exposure of BPA analogues has not been reported using NHPs but only in mouse models.¹⁷ Studies on BPA have been shown to impact the midbrain dopamine neurons and hippocampal spine synapses in NHPs.⁴¹ The results showed that exposure to BPA induced abnormalities in the foetal ventral mesencephalon and hippocampus in two months pregnant rhesus monkeys. Consequently, the same study showed a reduction in spine hippocampal synapses among juvenile vervet monkeys upon BPA exposure. Various research has revealed that consistent developmental exposure to EDCs (including BPA) interferes with the response of animal models to hormonal challenges later in life. Upon BPA and its analogues, Kathryn et al. showed that developmental exposures to BPA alters gene expression in foetal rhesus macaque uterus after the third trimester exposure leading to transcriptional signals in the uterus.⁴² Table 4 summarises studies on exposure to BPA and its analogues using NHP models.

Table 4.

Summary of studies on exposure to BPA and its analogues using NHP models.

Authors	Bisphenols	Model type	Sample type	Objectives	Risk effects (odds ratio and relative risks)
Aldad et al.²⁸	Bisphenol A	African green monkey	Ovaries	To evaluate the effect of bisphenol-A (BPA), a xenoestrogen endocrine disruptor, on endometrial P receptor (PR) expression in nonhuman primates and human cells.	Increased relative risk of 2.8 for the exposed group that alters endometrial progesterone receptor expression leading to endometriosis
Calhoun et al.¹⁵		Rhesus macaques	Foetal uteri	To determine if maternal oral BPA exposure affects foetal uterine development in a non-human primate model	Not reported

NHPs for BPA exposure as a potential cause of endometriosis

Early studies on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in rhesus macaques had revealed that the incidence of endometriosis correlates with dioxin exposure in a dose-dependent manner.⁴³ Moreover, a study on chronic exposure to dioxin correlated with endometriosis and increased PCB serum levels, suggested a possible contribution of endocrine disruptors in the pathogenetic mechanism of rhesus monkeys.⁴⁴ Regarding specific effects of BPA, Calhoun et.al. showed that BPA exposure alters developmental gene expression in the foetal rhesus macaque uterus hence causing future transcriptional signals.¹⁵ A study on NHPs in African green monkeys with BPA exposure reported a potential cause of endometriosis as BPA affects the balance between estrogen and progesterone action. This imbalance leads to increased estrogenic action that is associated with conditions characterised by the development of endometrial proliferation and diminished differentiation, including endometriosis.²⁸ Nonetheless, apart from in vivo studies of both NHPs and non-primate models, in vitro studies have also been used with endometriosis studies. Gu et al.¹³ reported a summary of both in vivo and in vitro studies used in the previous decade. Upon in vitro studies the human endometriotic primary cell lines have been used for preclinical research. They include; endometrial organoids, epithelial progenitors, mesenchymal stem cells and endometriotic stromal cell lines. Particularly, organoid models and in vitro co-culture systems aim at recapitulating the complex cellular and extracellular matrix composition of the endometriotic lesions and may provide an important intermediate model bridging single-cell in vitro models and animal models.⁴⁵

Discussion

The review performed a literature search of experimental animal studies which examined the EDC of BPA and its analogues. While several studies monitored non-primate animals, the association between these endocrine disrupters’ exposure and the female reproductive function focusing on endometriosis has not been explored in NHPs.⁴⁶ Here, we have reviewed the current literature on BPA with its analogues and summarised the current state of knowledge.

Due to increased industrialisation, thousands of man-made chemicals have been developed with few undergoing rigorous safety assessments before commercial use. Ubiquitous exposure to these compounds, many of which act as EDCs, including BPA, has been suggested to contribute to the increasing incidence of numerous diseases, including endometriosis.⁵ BPA exposure has been associated with an increase in the body’s inflammatory reactions.⁴⁷ Inflammation plays a crucial role in the development of lesions, adhesions and discomfort in endometriosis. Additionally, BPA exposure has been linked to epigenetic changes, which can affect gene expression without altering the underlying DNA sequence. Endometriosis progression and growth may be influenced by epigenetic modifications that lead to the dysregulation of genes involved in hormones and immunological function.⁴⁸

Many EDCs including BPA have been confirmed to dysregulate the immune system.⁴⁷ This potentially impairs the body’s ability to recognise and destroy aberrant endometrial tissue. The development and function of the female reproductive tract depend on hormone concentrations and balance. Endocrine disruptors interfere with the synthesis, metabolism and action of hormones, leading to the dysregulation of normal physiological processes and potentially promoting the development of diseases. Endometriosis is intimately associated with steroid metabolism and associated pathways, corresponding to the dominant roles estrogen receptors (ESRs) and progesterone receptors (PGRs) play in uterine biology.¹² Therefore, environmental toxicants that either mimic estrogen or enhance estrogenic exposure in the endometrium are thought to increase the risk of endometriosis. BPA as an endocrine disrupter has been reported to exert estrogenic activity which may interfere with the female reproductive system.¹⁶

Animal studies show the association between exposure to BPA and the development of endometriosis. The action of BPA is reported to be similar to the action of estrogens in animals. Additional epidemiological studies have indicated that BPA exposure may potentially be associated with alterations in hormone levels and impairment of ovary and uterine functions.³⁵ Despite several studies on endometriosis using NHPs,⁴⁹ few studies have assessed the relationship between endometriosis and BPA in these animals.²⁸ BPA as a known endocrine disruptor has been shown to be a reproductive toxicant in animal models, its structural analogues are increasingly being used in consumer products. However, these analogues may exert similar adverse effects on the reproductive system and their epidemiological studies and toxicological data are still scarce.

Most of the world population is still widely exposed to BPA, due to its large use in the production of polycarbonate plastic and its release into foods and beverages. Recently, the prevalence of BPA analogs in the environment, foods, consumer products and human urine samples have been reported.⁵⁰ With high degrees of structural similarities to BPA, these analogues may potentially have a similar endocrine-disrupting capacity and the potential to exert adverse effects on the reproductive system. Numerous studies have investigated the reproductive toxicity of BPA and its analogues in rodents. Unlike rodents, an animal model that more reliably simulates endometriosis pathogenesis and pathophysiology is only possible in NHPs.⁵¹ Studies indicate that amongst the NHPs, olive baboons (Papio anubis)¹⁹ serve as the gold standard model for endometriosis research due to their reproductive physiological similarities to humans.¹⁹ Studies conducted in Kenya have shown that baboons can develop spontaneous endometriosis thus making an exceptional model for the etiological and pathological research of the disease.⁵²

Conclusion

Though endometriosis is a common disorder of unknown etiology, research indicates a relationship between bisphenol A exposure as well as its concentration in body fluids and the occurrence of endometriosis in women. The studies reviewed here provide insufficient toxicological and epidemiological data to characterise and determine the reproductive effects of BPA and its analogues.² The potential mechanisms of BPA and its analogues in contributing to human disease are unclear. Thus, considering that the incidence and/or prevalence of reproductive health problems associated with endocrine disruption has increased worldwide, further detailed studies using NHPs, in particular, P. anubis, are needed to specify the role of bisphenol A and its analogues in the etiology of endometriosis.⁵³ The significant individual and public health concerns underscore the importance of understanding the pathogenesis of endometriosis.⁵⁴ Though some evidence exists pointing to possible connections between BPA exposure and endometriosis, additional research is required to fully understand the mechanism of action.

Footnotes

Acknowledgements

The completion of this review was made possible by the joint efforts and contributions of many people and organisations. We extend our heartfelt thanks to the academics and scientists whose work established the groundwork for the studies covered in this review. Their commitment to advance research in the subject has helped shape our understanding of the possible linkages between Bisphenol A with its analogues and endometriosis in non-human primates.

Data availability statement

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iDs

Oreng’ P Apiyo

Ivy J Mutai

References

Malvezzi

Marengo

Podgaec

, et al. Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology. J Transl Med 2020; 18(1): 1–21.

Sirohi

Al Ramadhani

Knibbs

. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review. Rev Environ Health 2021; 36(1): 101–115.

Bougie

Nwosu

Warshafsky

. Revisiting the impact of race/ethnicity in endometriosis. Reprod Fertil 2022; 3(2): R34–R41.

Interdonato

Siracusa

Fusco

, et al. Endocrine disruptor compounds in environment: focus on women’s reproductive health and endometriosis. Int J Mol Sci 2023; 24(6): 5682.

Piazza

Urbanetz

. Environmental toxins and the impact of other endocrine disrupting chemicals in women’s reproductive health. JBRA Assist Reprod 2019; 23(2): 154–164.

Dutta

Banu

Arosh

. Endocrine disruptors and endometriosis. Reprod Toxicol Elmsford N 2023; 115: 56–73.

Saunders

PTK

Horne

. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell 2021; 184(11): 2807–2824.

Persoons

De Clercq

Van den Eynde

, et al. Mimicking Sampson’s retrograde menstrual theory in rats: a new rat model for ongoing endometriosis-associated pain. Int J Mol Sci 2020; 21(7): 2326.

Velho

Danielyan

Mechsner

, et al. Sox-2 positive cells identified in lymph nodes from endometriosis patients may play a role in the disease pathogenesis. Eur J Obstet Gynecol Reprod Biol 2023; 288: 124–129.

10.

Laganà

Garzon

Götte

, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20(22): 5615.

11.

Vandenberg

Hauser

Marcus

, et al. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24(2): 139–177.

12.

Wieczorek

Szczęsna

Jurewicz

. Environmental exposure to non-persistent endocrine disrupting chemicals and endometriosis: a systematic review. Int J Environ Res Public Health 2022; 19(9): 5608.

13.

Jia

Leng

. Establishment of endometriotic models: the past and future. Chin Med J 2020; 133(14): 1703–1710.

14.

Xue

Yao

Ting

, et al. BPA modulates the WDR5/TET2 complex to regulate ERβ expression in Eutopic endometrium and drives the development of endometriosis. Environ Pollut Barking Essex 1987 2021; 268(Pt B): 115748.

15.

Calhoun

Padilla-Banks

Jefferson

, et al. Bisphenol A exposure alters developmental gene expression in the fetal rhesus macaque uterus. PLoS One 2014; 9(1): e85894.

16.

Kawa

Akbar

Fatima

, et al. Endocrine disrupting chemical Bisphenol A and its potential effects on female health. Diabetes Metab Syndr 2021; 15(3): 803–811.

17.

Jones

Lang

Kendziorski

, et al. Use of a mouse model of experimentally induced endometriosis to evaluate and compare the effects of bisphenol a and bisphenol af exposure. Environ Health Perspect 2018; 126(12): 1–14.

18.

Pivonello

Muscogiuri

Nardone

, et al. Bisphenol A: an emerging threat to female fertility. Reprod Biol Endocrinol 2020; 18(1): 22.

19.

D’Hooghe

Nyachieo

Chai

, et al. Reproductive research in non-human primates at institute of primate Research in Nairobi, Kenya (WHO collaborating center): a platform for the development of clinical infertility services? ESHRE Monogr 2008; 1: 102–107.

20.

Abril-Coello

Correyero-León

Ceballos-Laita

, et al. Benefits of physical therapy in improving quality of life and pain associated with endometriosis: a systematic review and meta-analysis. Int J Gynaecol Obstet 2023; 162(1): 233–243.

21.

Stavridis

Triantafyllidou

Pisimisi

, et al. Bisphenol-A and female fertility: an update of existing epidemiological studies. J Clin Med 2022; 11(23): 7227.

22.

Karthikraj

Lee

Kannan

. Biomonitoring of exposure to bisphenols, benzophenones, triclosan, and triclocarban in pet dogs and cats. Environ Res 2020; 180: 108821.

23.

Hill

Sapouckey

Suvorov

, et al. Developmental exposures to bisphenol S, a BPA replacement, alter estrogen-responsiveness of the female reproductive tract: a pilot study. Cogent Med 2017; 4(1): 1317690.

24.

Peinado

Lendínez

Sotelo

, et al. Association of urinary levels of Bisphenols A, F, and S with endometriosis risk: preliminary results of the EndEA study. Int J Environ Res Public Health 2020; 17(4): 1194.

25.

Cobellis

Colacurci

Trabucco

, et al. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed Chromatogr 2009; 23(11): 1186–1190.

26.

Rashidi

Amanlou

Lak

, et al. A case-control study of bisphenol A and endometrioma among subgroup of Iranian women. J Res Med Sci 2017; 22(1): 7.

27.

Wen

Xiong

Jin

, et al. Bisphenol A exposure enhances endometrial stromal cell invasion and has a positive association with peritoneal endometriosis. Reprod Sci 2020; 27(2): 704–712.

28.

Aldad

Rahmani

Leranth

, et al. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril 2011; 96(1): 175–179.

29.

Signorile

Spugnini

Mita

, et al. Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol 2010; 168(3): 318–325.

30.

Signorile

Baldi

. 7. Endocrine disruptors and endometriosis: the role of BPA. In: Mita

(ed.) Endocrine disruptors and their effect on environment and human health. Kerala, India: Research Signpost, 2018, pp.159–169.

31.

Shi

Sekulovski

MacLean

, et al. Prenatal exposure to Bisphenol A analogues on female reproductive functions in mice. Toxicol Sci 2019; 168(2): 561–571.

32.

Abdel-Wahab

Hassanin

KMA

Ibrahim

, et al. Developmental programming: physiological impacts of prenatal melatonin administration on reproductive capacity and serum triiodothyronine of adult female offspring rat born to moms exposed to Bisphenol A during pregnancy. Reprod Sci 2021; 28(7): 1956–1966.

33.

Kendziorski

Belcher

. Strain-specific induction of endometrial periglandular fibrosis in mice exposed during adulthood to the endocrine disrupting chemical bisphenol A. Reprod Toxicol Elmsford N 2015; 58: 119–1130.

34.

Horan

Pulcastro

Lawson

, et al. Replacement bisphenols adversely affect mouse gametogenesis with consequences for subsequent generations. Curr Biol 2018; 28(18): 2948–2954.e3.

35.

Siracusa

Yin

Measel

, et al. Effects of bisphenol A and its analogs on reproductive health: a mini review. Reprod Toxicol Elmsford N 2018; 79: 96–123.

36.

Polak

Banaszewska

Filip

, et al. Environmental factors and endometriosis. Int J Environ Res Public Health 2021; 18(21): 11025.

37.

Bellelis

Podgaec

Brão

. Environmental factors and endometriosis. Rev Assoc Médica Bras Engl Ed 2011; 57(4): 448–452.

38.

Kundakovic

Gudsnuk

Franks

, et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol a exposure. Proc Natl Acad Sci USA 2013; 110(24): 9956–9961.

39.

Santoro

Chianese

Troisi

, et al. Neuro-toxic and Reproductive Effects of BPA. Curr Neuropharmacol 2019; 17(12): 1109–1132.

40.

Harnett

Moore

Chin

, et al. Teratogenicity and toxicity of the new BPA alternative TMBPF, and BPA, BPS, and BPAF in chick embryonic development. Curr Res Toxicol 2021; 2: 399–410.

41.

Elsworth

Jentsch

VandeVoort

, et al. Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. NeuroToxicology 2013; 35(1): 113–120.

42.

Calhoun

Padilla-Banks

Jefferson

, et al. Bisphenol A exposure alters developmental gene expression in the fetal rhesus macaque uterus. PLoS One 2014; 9(1): e85894.

43.

Rier

Martin

Bowman

, et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993; 21(4): 433–441.

44.

Rier

Turner

Martin

, et al. Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol Sci 2001; 59(1): 147–159.

45.

Stejskalová

Vankelecom

Sourouni

, et al. In vitro modelling of the physiological and diseased female reproductive system. Acta Biomater 2021; 132: 288–312.

46.

Wen

Xiong

, et al. The risk of endometriosis after exposure to endocrine-disrupting chemicals: a meta-analysis of 30 epidemiology studies. Gynecol Endocrinol 2019; 35(8): 645–650.

47.

Wei

Liang

Lin

, et al. Autonomic nervous system and inflammation interaction in endometriosis-associated pain. J Neuroinflammation 2020; 17(1): 80.

48.

Giacomini

Minetto

Li Piani

, et al. Genetics and inflammation in endometriosis: improving knowledge for development of new pharmacological strategies. Int J Mol Sci 2021; 22(16): 9033.

49.

DHooghe

Mwenda

Hill

. The Baboon as a Nonhuman primate model for the study of human reproduction. Gynecol Obstet Invest 2004; 57(1): 1–60.

50.

Akash

MSH

Rasheed

Rehman

, et al. Toxicological evaluation of bisphenol analogues: preventive measures and therapeutic interventions. RSC Adv 2023; 13(31): 21613–21628.

51.

D’Hooghe

Bambra

Cornillie

, et al. Prevalence and laparoscopic appearance of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus). Biol Reprod 1991; 45(3): 411–416.

52.

D’Hooghe

Debrock

. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 2002; 8(1): 84–88.

53.

Nyachieo

Chai

Deprest

, et al. The baboon as a research model for the study of endometrial biology, uterine receptivity and embryo implantation. Gynecol Obstet Invest 2007; 64(3): 149–155.

54.

Moreira Fernandez

Cardeal

Carneiro

, et al. Study of possible association between endometriosis and phthalate and bisphenol A by biomarkers analysis. J Pharm Biomed Anal 2019; 172: 238–242.

A review: Exposure to bisphenol a analogues in non-human primates as a potential cause of endometriosis

Abstract

Introduction:

Methods:

Results:

Conclusion:

Keywords

Introduction

Methodology

BPA and its analogues as potential cause of endometriosis

Use of animal models for BPA exposure

NHP models for BPA exposure

NHPs for BPA exposure as a potential cause of endometriosis

Discussion

Conclusion

Footnotes

Acknowledgements

Data availability statement

Declaration of conflicting interests

Funding

ORCID iDs

References